These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8732680

  • 1. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS, Wimalasena J.
    Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
    [Abstract] [Full Text] [Related]

  • 2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 3. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 18; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 4. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907
    [Abstract] [Full Text] [Related]

  • 5. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
    Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A.
    Oncogene; 1996 Jun 06; 12(11):2315-24. PubMed ID: 8649771
    [Abstract] [Full Text] [Related]

  • 6. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ.
    Cancer Res; 1996 Jul 01; 56(13):2973-8. PubMed ID: 8674031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS, Prall OW, Musgrove EA, Sutherland RL.
    J Biol Chem; 2000 Dec 08; 275(49):38221-9. PubMed ID: 10991938
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.
    Mol Carcinog; 1997 Feb 08; 18(2):107-14. PubMed ID: 9049186
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 08; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 12. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.
    Mol Cell Biol; 1998 Aug 08; 18(8):4499-508. PubMed ID: 9671459
    [Abstract] [Full Text] [Related]

  • 13. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA, Sarcevic B, Sutherland RL.
    J Cell Biochem; 1996 Mar 01; 60(3):363-78. PubMed ID: 8867812
    [Abstract] [Full Text] [Related]

  • 14. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
    Dees C, Garrett S, Henley D, Travis C.
    Radiat Res; 1996 Oct 01; 146(4):444-52. PubMed ID: 8927716
    [Abstract] [Full Text] [Related]

  • 15. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
    Wang W, Smith R, Safe S.
    Arch Biochem Biophys; 1998 Aug 15; 356(2):239-48. PubMed ID: 9705214
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors.
    Kwon TK, Buchholz MA, Chrest FJ, Nordin AA.
    Cell Growth Differ; 1996 Oct 15; 7(10):1305-13. PubMed ID: 8891334
    [Abstract] [Full Text] [Related]

  • 18. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Aug 25; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 20. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM, Saucier C, Bedin M, Barbu V, Mester J.
    Int J Cancer; 2004 Jan 10; 108(2):200-6. PubMed ID: 14639603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.